Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Antibiotic resistance is a growing global health threat.
• Understanding antibiotic mechanisms of action is critical for developing new drugs.
• Peptidoglycan precursor lipid II is a validated target for several antibiotic classes.

Purpose of the Study:

• To review different classes of antibiotics that target lipid II.
• To discuss the mechanisms of action of these lipid II-targeting agents.
• To highlight the potential of lipid II as a target for future antibacterial drug development.

Main Methods:

• Literature review of existing research on lipid II-targeting antibiotics.
• Detailed discussion of antibiotic classes including lantibiotics, human invertebrate defensins, and teixobactin.
• Analysis of the mode of action for each discussed antibiotic class.

Main Results:

• Several classes of antibiotics, including lantibiotics, defensins, and teixobactin, effectively target lipid II.
• Targeting lipid II disrupts essential bacterial processes, leading to cell death.
• Teixobactin represents a recently discovered and promising lipid II-targeting antibiotic.

Conclusions:

• Lipid II is a highly effective target for developing novel antibacterial strategies.
• Further research into lipid II-targeting antibiotics can lead to potent agents against resistant microorganisms.
• The development of new antibiotics targeting lipid II holds significant promise for combating bacterial infections.